OUR JOURNAL PARTNER
Metabolism and Target Organ Damage (M&TOD) is an international, peer-reviewed, open access scientific journal which provides an online platform for publication of clinical, basic and translational studies. M&TOD, characterized by a strong interdisciplinary personality covers (cardio)-metabolic disorders per se, such as obesity, diabetes, dyslipidemias, arterial hypertension and hyperuricemia in all age groups. Of note, this journal will emphasize the role of these metabolic disorders as either effectors/amplifiers or consequences of the development and progression of injuries to target organs including but not limited to the cardiovascular system, the liver, kidneys and the pancreas.
Areas which will be covered, specifically applied to metabolic disorders, are as follows: history of disease, epidemiology, prevention, natural history, genetics, cell and molecular biology, pathobiochemistry, physiopathology, anatomic pathology, clinical chemistry, pharmaceutical chemistry, pharmacology, psychology, psychiatry, statistics and immunology. From a clinical point of view, we are interested in biomarkers, diagnosis, prognosis and all types of innovative management strategies including cognitive-behavioral approaches and randomized controlled trials of innovative drug schedules of metabolic disorders. M&TOD promotes the development of animal-free models of studies including cell cultures, artificial intelligence and others.
The first issue will be coming soon and the journal welcome high-quality manuscripts of the following editorial categories: Original Article, Review, Case Report, Commentary, Mini-Review, Systematic Review, Meta-analysis, Editorial, Perspective, Opinion, Communication, Letter and Research Highlight. Click https://www.oaemesas.com/mtod to submit your paper!
Should you have more questions about this journal, please feel free to contact the Editorial Office at email@example.com